The Net Margin of Aspira Pathlab & Diagnostics Ltd (540788.BO) is 9.19%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 9.19% |
| 2024-03-31 | -20.24% |
| 2023-03-31 | -0.61% |
| 2022-03-31 | 22.82% |
| 2021-03-31 | 9.08% |
| 2020-03-31 | -50.39% |
| 2019-03-31 | -67.86% |
| 2018-03-31 | -128.10% |
| 2017-03-31 | -359.09% |